Zofran Birth Defect MDL Judge: Plaintiff Consultant Is Subject To Discovery

Mealey's (July 30, 2019, 2:56 PM EDT) -- BOSTON — The Massachusetts federal judge overseeing the Zofran birth defect multidistrict litigation on July 25 ordered plaintiffs’ counsel and a plaintiffs’ epidemiologist to produce to defendant GlaxoSmithKline LLC (GSK) documents the researcher used in writing a medical journal article on which the plaintiffs rely for causation and to disclose her communications and financial arrangements with plaintiffs’ counsel (In Re: Zofran [Ondansetron] Products Liability Litigation, MDL Docket No. 2657, No. 15-md-2657, D. Mass., 2019 U.S. Dist. LEXIS 123913)....

Attached Documents

Related Sections